Medium Term Outcomes for Robotic Sacral Colpopexy With Autologous Fascia Lata
- PMID: 40575932
- PMCID: PMC12264459
- DOI: 10.1002/nau.70094
Medium Term Outcomes for Robotic Sacral Colpopexy With Autologous Fascia Lata
Abstract
Objectives: To evaluate the medium-term outcomes of robotic sacral colpopexy (RSC) using autologous fascia lata for the treatment of apical pelvic organ prolapse.
Methods: An IRB-approved retrospective review was conducted on patients who underwent RSC with autologous fascia lata at a single institution between November 2017 and August 2022. Only patients with a minimum of 24 months of follow-up were included as short-term results have already been published. Data collected included patient demographics, operative details, surgical complications, Pelvic Organ Prolapse Quantification (POP-Q) measurements, and patient-reported outcomes using the Urogenital Distress Inventory-6 (UDI-6) and Incontinence Impact Questionnaire-7 (IIQ-7). The primary outcome was the medium-term durability of autologous fascia lata RSC, with recurrence defined as > 0 cm from the hymen in any compartment on postoperative POP-Q examination or recurrence at the apex of ≥ 2 cm.
Results: Nineteen patients met the inclusion criteria, with a mean follow-up of 42.8 ± 11.9 months. All POP-Q values showed significant improvement postoperatively, with only one (6.3%) patient experiencing posterior compartment recurrence and one (6.3%) with exactly 2 cm of apical descent. One patient (5.2%) required surgical retreatment with posterior colporrhaphy and a pubovaginal sling. Patient-reported outcomes demonstrated significant improvement in UDI-6 and IIQ-7 scores (p < 0.05). Minor complications related to fascia lata harvest were observed, including seroma (10.5%), transient paresthesia (21%), hematoma (5.2%), and deep vein thrombosis (5.2%), with most resolving spontaneously.
Conclusions: RSC with autologous fascia lata provides durable medium-term anatomic and symptomatic improvement for apical POP, with low recurrence and retreatment rates. While minor harvest-related complications were observed, most were self-limiting. These findings support the use of autologous fascia lata as a viable alternative to synthetic mesh in RSC. Larger, multicenter studies with extended follow-up are needed to further validate these results.
Keywords: fascia lata; follow‐up studies; pelvic organ prolapse; robotic surgical procedures; surgical mesh.
© 2025 The Author(s). Neurourology and Urodynamics published by Wiley Periodicals LLC.
Conflict of interest statement
Charles R. Powell: Medtronic—investigator; Neuspera—investigator; AUA Practice Guidelines Committee—member; Oakstone Medical Publishing—editor; Wiley Publishing—editorial board; Springer Publishing—section editor. The other authors declare no conflicts of interest.
Figures
References
-
- Costantini E., Brubaker L., Cervigni M., et al., “Sacrocolpopexy for Pelvic Organ Prolapse: Evidence‐Based Review and Recommendations,” European Journal of Obstetrics & Gynecology and Reproductive Biology 205 (2016): 60–65. - PubMed
-
- “FDA's Activities: Urogynecologic Surgical Mesh,” US Food and Drug Administration, 2022.
-
- Bock M. E., Nagle R., Soyster M., et al., “Robotic Sacral Colpopexy Using Autologous Fascia Lata Compared With Mesh,” Journal of Endourology 35, no. 6 (2021): 801–807. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
